Robert Michael
Patrimonio netto: 45 M $ in data 30/06/2026
Patrimonio netto: 45 M $ in data 30/06/2026
Robert A. Michael è Chief Financial Officer & Executive Vice President di AbbVie, Inc. e Chief Executive Officer di Fremont Holding LLC, Chief Executive Officer di Tobira Therapeutics, Inc. e President & Director di Allergan Plc (che sono tutte filiali di AbbVie, Inc.). Il signor Michael fa anche parte del consiglio di amministrazione di AbbVie Biotherapeutics Ltd. Il signor Michael ha precedentemente ricoperto la posizione di controllore di divisione - catena di approvvigionamento alimentare presso Abbott Laboratories. Ha ricevuto un MBA dalla Anderson School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ABBVIE, INC. 0,01% | 06/03/2026 | 178.737 ( 0,01% ) | 45 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ABBVIE INC. | Amministratore Delegato | 01/07/2024 |
| ALLERGAN PLC | Presidente | 08/05/2020 |
| TOBIRA THERAPEUTICS INC | Amministratore Delegato | - |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 01/04/2019 |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Amministratore Delegato | - |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | Presidente | 01/01/2022 |
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/2012 |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | Commercial Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale